Industry Leaders Panel Discussion: Starting With End Goals in Mind – Defining Patient-Centric Peptide Drug Delivery & Formulations to Improve Patient Adherence & Patient Outcomes
Time: 9:00 am
day: Day One
Details:
- Using patient population characteristics to define optimal and impactful peptide therapeutic formulation and modes of administration
- Considering age-appropriate formulations, drug dosing, ability to self-administer, disease characteristics, disease severity, patient experience of treatment and other factors
- Balancing unmet patient needs with commercial value and differentiation of peptide therapeutic product formulation and delivery
